Nintedanib Esylate | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Nintedanib Esylate
US Exclusivities

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

pharmacompass-1-m-2026-01-12

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

Contact Supplier

Nintedanib Esylate

Contact Supplier

pharmacompass-2-2026-02-09

Nintedanib Esylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 23 USDMF, 7 EU WC, 13 KDMF, 16 NDC API, 26 Listed Suppliers, $ API Reference Price

53 API Suppliers
23 USDMF
7 EU WC
13 KDMF
16 NDC API
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

106 Drugs in Development

106 Drugs in Development

INTERMEDIATES

31 Intermediate Suppliers

31 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

144 FDF Dossiers, 15 FDA Orange Book, 111 Europe, 4 Canada, 4 Australia, 4 South Africa, 6 Listed Dossiers

144 FDF Dossiers
15 FDA Orange Book
111 Europe
4 Canada
4 Australia
4 South Africa
6 Listed Dossiers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 76 News #PharmaBuzz

1 Data Compilation #PharmaFlow
76 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 5 Annual Reports

1 US Medicaid Prescriptions
2 Regulatory FDF Prices
5 Annual Reports

MARKET PLACE

7 APIs, 6 FDF Dossiers

7 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 US Patents, 4 US Exclusivities, 10 Health Canada Patents

16 US Patents
4 US Exclusivities
10 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

$ API Ref.Price (USD/KG) : 2,803 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

4 All

01 4BOEHRINGER INGELHEIM

filter Product Reset all filters

4 All

01 4NINTEDANIB ESYLATE

filter Exclusivity Expiration Date Reset all filters

4 All

01 22026-09-06

02 22027-03-06

filter Exclusivity Code Reset all filters

4 All

01 2ODE-261

02 2PED

Product Main Page

BOEHRINGER INGELHEIM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

NINTEDANIB ESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2027-03-06

Application Number

205832

Product Number

2

Exclusivity Details

01

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

International Sweetener Colloquium

Not Confirmed

BOEHRINGER INGELHEIM

Germany

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NINTEDANIB ESYLATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2027-03-06

Application Number : 205832

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BOEHRINGER INGELHEIM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

NINTEDANIB ESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2027-03-06

Application Number

205832

Product Number

1

Exclusivity Details

02

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

International Sweetener Colloquium

Not Confirmed

BOEHRINGER INGELHEIM

Germany

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NINTEDANIB ESYLATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2027-03-06

Application Number : 205832

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BOEHRINGER INGELHEIM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

NINTEDANIB ESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-261

Exclusivity Expiration Date

2026-09-06

Application Number

205832

Product Number

2

Exclusivity Details

03

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

International Sweetener Colloquium

Not Confirmed

BOEHRINGER INGELHEIM

Germany

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NINTEDANIB ESYLATE

Exclusivity Code : ODE-261

Exclusivity Expiration Date : 2026-09-06

Application Number : 205832

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BOEHRINGER INGELHEIM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

NINTEDANIB ESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-261

Exclusivity Expiration Date

2026-09-06

Application Number

205832

Product Number

1

Exclusivity Details

04

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

International Sweetener Colloquium

Not Confirmed

BOEHRINGER INGELHEIM

Germany

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NINTEDANIB ESYLATE

Exclusivity Code : ODE-261

Exclusivity Expiration Date : 2026-09-06

Application Number : 205832

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.